Weatherly International shines bright as small caps go higher
UK small caps were outshining big caps in early deals with copper junior Weatherly International PLC the runaway gainer.
Company
LON:OPTI
OptiBiotix Health Plc is a life sciences company operating in one of the most progressive areas of biotechnological research. Developing and commercialising technologies that modulate the human microbiome – the collective genome of the microbes in the body – the company identifies and develops prebiotic formulations and compounds for use in food ingredients and supplements that can impact on human physiology and metabolism, deriving potential health benefits.
574 stories · page 26 of 29
UK small caps were outshining big caps in early deals with copper junior Weatherly International PLC the runaway gainer.
There's a flurry of interesting small cap firms reporting this week, alongside AIM internet retail biggie ASOS....
Archive
Better news for Westminster group, a 'transformational' year for Alliance Pharma and Victoria Oil & Gas secures government approval.
The supplement could reduce cholesterol and blood pressure
Archive
Silence Therapeutics new drug's oncology potential, deferral of debt for Aureus Mining and strong trading for PureCircle.
DSM is one of the world's leading suppliers of nutritional ingredients
Chief of life sciences group OptiBiotix Health PLC Stephen OHara says increased rates of global obesity should boost demand for his firm's products.
OptiBiotix Health PLC, the life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has signed a second collaboration agreement with an arm of the Spanish National Research Council.
Archive
Sirius Minerals' "world class" North Yorkshire project, update on Aureus and Allergy Therapeutics to lose finance director.
The company is using its knowledge of this emerging area of science to develop treatments that tackle cholesterol and obesity.
Spector’s appointment creates opportunities to collaborate and additional insight into the role of the microbiome in health and disease, Optibiotix highlighted.
Archive
After briefly venturing back above 6,000, the Footsie saw its gains trimmed as US markets turned lower.
If everyone could be as active as the York-based outfit there would not be such a pressing demand for its products.
Investors shrug off 'We're done for' predictions to push shares higher
Premier Oil is eyeing up the North Sea assets of German utility company Eon, according to reports.
The SlimBiome product could be commercialised by KSF Acquisition, the company behind the SlimFast brand in the UK, Ireland and Germany.
Read it and weep blue-chip backers: the AIM 100 trounced the FTSE 100 in 2015, and sported some sensational performances.
Archive
FTSE100, the UK's premier share index, closed out the year around 25 points lower in a curtailed trading day...
Archive
Atlantic Coal mulls leaving AIM while Caledonia Mining proposes moving its HQ to Jersey
Investments and investor services
The FTSE100 ended the day almost 15 points lower to 6,223.